23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The superfamily keeps growing: Identification in trypanosomatids of RibJ, the first riboflavin transporter family in protists

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Trypanosomatid parasites represent a major health issue affecting hundreds of million people worldwide, with clinical treatments that are partially effective and/or very toxic. They are responsible for serious human and plant diseases including Trypanosoma cruzi (Chagas disease), Trypanosoma brucei (Sleeping sickness), Leishmania spp. (Leishmaniasis), and Phytomonas spp. (phytoparasites). Both, animals and trypanosomatids lack the biosynthetic riboflavin (vitamin B2) pathway, the vital precursor of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) cofactors. While metazoans obtain riboflavin from the diet through RFVT/SLC52 transporters, the riboflavin transport mechanisms in trypanosomatids still remain unknown.

          Methodology/Principal findings

          Here, we show that riboflavin is imported with high affinity in Trypanosoma cruzi, Trypanosoma brucei, Leishmania (Leishmania) mexicana, Crithidia fasciculata and Phytomonas Jma using radiolabeled riboflavin transport assays. The vitamin is incorporated through a saturable carrier-mediated process. Effective competitive uptake occurs with riboflavin analogs roseoflavin, lumiflavin and lumichrome, and co-factor derivatives FMN and FAD. Moreover, important biological processes evaluated in T. cruzi (i.e. proliferation, metacyclogenesis and amastigote replication) are dependent on riboflavin availability. In addition, the riboflavin competitive analogs were found to interfere with parasite physiology on riboflavin-dependent processes. By means of bioinformatics analyses we identified a novel family of riboflavin transporters (RibJ) in trypanosomatids. Two RibJ members, TcRibJ and TbRibJ from T. cruzi and T. brucei respectively, were functionally characterized using homologous and/or heterologous expression systems.

          Conclusions/Significance

          The RibJ family represents the first riboflavin transporters found in protists and the third eukaryotic family known to date. The essentiality of riboflavin for trypanosomatids, and the structural/biochemical differences that RFVT/SLC52 and RibJ present, make the riboflavin transporter -and its downstream metabolism- a potential trypanocidal drug target.

          Author summary

          In this work, we show that riboflavin plays a key role in the trypanosomatid life cycles and describe a novel family of riboflavin transporters (RibJ) with uptake function. Despite the vital importance of riboflavin for all living cells, RibJ are the first transporters described in protists. We functionally characterized the T. cruzi and T. brucei RibJ members and the effect of riboflavin analogs on parasite physiology. The structural and biochemical differences presented between human transporters and RibJ members make riboflavin transport and downstream metabolism, attractive and potential trypanosomatid targets.

          Related collections

          Most cited references77

          • Record: found
          • Abstract: found
          • Article: not found

          Major facilitator superfamily.

          The major facilitator superfamily (MFS) is one of the two largest families of membrane transporters found on Earth. It is present ubiquitously in bacteria, archaea, and eukarya and includes members that can function by solute uniport, solute/cation symport, solute/cation antiport and/or solute/solute antiport with inwardly and/or outwardly directed polarity. All homologous MFS protein sequences in the public databases as of January 1997 were identified on the basis of sequence similarity and shown to be homologous. Phylogenetic analyses revealed the occurrence of 17 distinct families within the MFS, each of which generally transports a single class of compounds. Compounds transported by MFS permeases include simple sugars, oligosaccharides, inositols, drugs, amino acids, nucleosides, organophosphate esters, Krebs cycle metabolites, and a large variety of organic and inorganic anions and cations. Protein members of some MFS families are found exclusively in bacteria or in eukaryotes, but others are found in bacteria, archaea, and eukaryotes. All permeases of the MFS possess either 12 or 14 putative or established transmembrane alpha-helical spanners, and evidence is presented substantiating the proposal that an internal tandem gene duplication event gave rise to a primordial MFS protein prior to divergence of the family members. All 17 families are shown to exhibit the common feature of a well-conserved motif present between transmembrane spanners 2 and 3. The analyses reported serve to characterize one of the largest and most diverse families of transport proteins found in living organisms.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              High-throughput decoding of anti-trypanosomal drug efficacy and resistance

              Summary The concept of specific chemotherapy was developed a century ago by Paul Ehrlich and others. Dyes and arsenical compounds that displayed selectivity against trypanosomes were central to this work 1,2 , and the drugs that emerged remain in use for treating Human African Trypanosomiasis (HAT) 3 . Ehrlich recognised the importance of understanding the mechanisms underlying selective drug action and resistance for the development of improved HAT therapies, but these mechanisms have remained largely mysterious. Here, we use all five current HAT drugs for genome-scale RNA interference (RNAi) target sequencing (RIT-seq) screens in Trypanosoma brucei, revealing the transporters, organelles, enzymes and metabolic pathways that function to facilitate anti-trypanosomal drug action. RIT-seq profiling identifies both known drug importers 4,5 and the only known pro-drug activator 6 , and links more than fifty additional genes to drug action. A specific bloodstream stage invariant surface glycoprotein (ISG75) family mediates suramin uptake while the AP-1 adaptin complex, lysosomal proteases and major lysosomal transmembrane protein, as well as spermidine and N-acetylglucosamine biosynthesis all contribute to suramin action. Further screens link ubiquinone availability to nitro-drug action, plasma membrane P-type H+-ATPases to pentamidine action, and trypanothione and multiple putative kinases to melarsoprol action. We also demonstrate a major role for aquaglyceroporins in pentamidine and melarsoprol cross-resistance. These advances in our understanding of mechanisms of anti-trypanosomal drug efficacy and resistance will aid the rational design of new therapies and help to combat drug resistance, and provide unprecedented levels of molecular insight into the mode of action of anti-trypanosomal drugs.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Negl Trop Dis
                PLoS Negl Trop Dis
                plos
                plosntds
                PLoS Neglected Tropical Diseases
                Public Library of Science (San Francisco, CA USA )
                1935-2727
                1935-2735
                13 April 2017
                April 2017
                : 11
                : 4
                : e0005513
                Affiliations
                [1 ]Laboratorio de Parasitología Molecular y Bioquímica, Instituto de Ciencia y Tecnología Dr. Cesar Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Saladillo, (C1440FFX) Ciudad Autónoma de Buenos Aires, Argentina
                [2 ]Laboratorio de Biología Celular y Molecular, Instituto de Histología y Embriología (IHEM), Universidad Nacional de Cuyo—Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Casilla de correo 56, Ciudad de Mendoza, Argentina
                [3 ]Laboratorio de Parasitología Molecular, Instituto de Investigaciones Médicas A. Lanari, Universidad de Buenos Aires—Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Combatientes de Malvinas, (C1427ARO) Ciudad Autónoma de Buenos Aires, Argentina
                [4 ]Fundación Instituto Leloir—Instituto de Investigaciones Bioquímicas Buenos Aires (IIBBA)—Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Av. Patricias Argentinas 435, (C1405BWE) Ciudad Autónoma de Buenos Aires, Argentina
                Harvard School of Public Health, UNITED STATES
                Author notes

                The authors have declared that no competing interests exist.

                • Conceptualization: DEB HRB CC.

                • Formal analysis: DEB HRB CAP CC.

                • Funding acquisition: CC FAG.

                • Investigation: DEB HRB MCV PSR.

                • Methodology: DEB HRB MCV PSR CC.

                • Project administration: HRB CC.

                • Resources: PSR FAG CC.

                • Supervision: HRB CC.

                • Visualization: DEB HRB CC.

                • Writing – original draft: DEB HRB CC.

                • Writing – review & editing: DEB HRB CAP CC.

                Article
                PNTD-D-16-02323
                10.1371/journal.pntd.0005513
                5404878
                28406895
                24a4a0d4-f522-4094-9089-12a4423d2db5
                © 2017 Balcazar et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 4 January 2017
                : 21 March 2017
                Page count
                Figures: 5, Tables: 1, Pages: 22
                Funding
                Funded by: Agencia Nacional de Promoción Científica y Tecnológica (AR)
                Award ID: FONCYT PICT 2012-0559
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/501100003074, Agencia Nacional de Promoción Científica y Tecnológica;
                Award ID: FONCYT PICT 2014-0959
                Award Recipient :
                Funded by: Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
                Award ID: PIP 2013-0664
                Award Recipient :
                This work was supported by CONICET ( http://www.conicet.gov.ar/) PIP 2013-0664 and Agencia Nacional de Promoción Científica y Tecnológica ( http://www.agencia.mincyt.gob.ar/) FONCYT PICT 2012-0559 and 2014-0959. DEB and MCV are CONICET research fellows, the other authors are members of CONICET scientific investigator system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Physical Sciences
                Chemistry
                Chemical Compounds
                Organic Compounds
                Vitamins
                B Vitamins
                Riboflavin
                Physical Sciences
                Chemistry
                Organic Chemistry
                Organic Compounds
                Vitamins
                B Vitamins
                Riboflavin
                Biology and Life Sciences
                Organisms
                Protozoans
                Parasitic Protozoans
                Trypanosoma
                Trypanosoma Cruzi
                Biology and Life Sciences
                Biochemistry
                Proteins
                Post-Translational Modification
                Flavin
                Biology and Life Sciences
                Organisms
                Protozoans
                Parasitic Protozoans
                Trypanosoma
                Trypanosoma Brucei Gambiense
                Biology and Life Sciences
                Developmental Biology
                Life Cycles
                Protozoan Life Cycles
                Epimastigotes
                Biology and Life Sciences
                Microbiology
                Protozoology
                Protozoan Life Cycles
                Epimastigotes
                Biology and Life Sciences
                Evolutionary Biology
                Evolutionary Systematics
                Phylogenetics
                Phylogenetic Analysis
                Biology and Life Sciences
                Taxonomy
                Evolutionary Systematics
                Phylogenetics
                Phylogenetic Analysis
                Computer and Information Sciences
                Data Management
                Taxonomy
                Evolutionary Systematics
                Phylogenetics
                Phylogenetic Analysis
                Medicine and Health Sciences
                Parasitic Diseases
                Biology and Life Sciences
                Biochemistry
                Metabolism
                Biological Transport
                Custom metadata
                vor-update-to-uncorrected-proof
                2017-04-25
                All relevant data are within the paper and its Supporting Information files.

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article